查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1710831

全球消化二胺氧化酶補充劑市場規模研究，依成分、最終劑型和區域預測，2022-2032

Global Digestive Diamine Oxidase Enzyme for Supplements Market Size study, by Ingredient, Final Dosage Form, and Regional Forecasts 2022-2032
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 285 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023年全球消化二胺氧化酶補充劑市場價值約為 238億美元，預計在2024-2032年預測期內將以超過 5.64%的年複合成長率成長。二胺氧化酶（DAO）補充劑已成為解決組織胺不耐受和相關消化失衡的重要飲食解決方案。隨著全球人口越來越關注腸道健康和全身炎症，DAO 在緩解胃腸不適、偏頭痛和食物敏感症狀方面的治療潛力推動其在補充劑領域的迅速應用。市場參與者將 DAO 策略性地定位在清潔標籤營養保健品中，目標是那些積極尋求針對慢性消化不適的針對性酵素干預措施的健康意識消費者。

推動該成長的因素有很多：功能性食品消費的急劇上升、個人化營養平台的擴展以及消費者越來越注重整體健康習慣。 DAO 在補充劑中的應用，特別是片劑、膠囊和粉末形式的應用，由於科學依據和組胺相關消化系統疾病的日益普及而擴大。酵素穩定和封裝技術的進步使得生物利用度和貨架穩定性更高，進一步增強了 DAO 注入配方的商業可行性。同時，主要市場的監管明確性以及 DAO 在醫生主導的治療方案中的日益普及為更廣泛的臨床認可奠定了基礎。

然而，市場並非沒有摩擦點。消費者對 DAO 在組胺分解中的具體作用的認知有限，尤其是在發展中經濟體，這仍然是一個瓶頸。高生產成本以及複雜的提取和淨化協議也限制了可擴展性。此外，來自通用消化酶混合物的競爭以及 DAO 相關研究的新興狀態繼續帶來策略風險。然而，這些挑戰催化創新，為植物酶替代品、符合素食主義的配方以及將 DAO 與益生菌和抗炎化合物協同作用的輔酶混合物鋪平道路。

將 DAO 酶整合到針對腸腦軸健康、皮膚活力和代謝和諧的多效益健康補充劑中，開闢前所未有的商業途徑。有影響力的品牌故事和直接面對消費者的分銷模式重塑競爭格局，特別是在數位化消費者的市場中。營養保健品製造商也與臨床研究人員合作，利用脂質體和延遲釋放技術設計生物可利用的DAO 傳輸機制。生物技術和消費者趨勢的融合增強了 DAO 對各個年齡層的吸引力，尤其是對易受組織胺敏感性影響的女性和老年人群。

從地區來看，北美引領全球 DAO 補充劑市場，這得益於強勁的膳食補充劑消費、較高的消費者健康素養以及強大的電子商務滲透率。歐洲緊隨其後，其營養基因組學應用不斷成長，標籤標準也越來越有利。同時，由於可支配收入的增加、對預防性醫療保健的興趣的增加以及中國、日本和印度等國家健康產業的蓬勃發展，預計亞太地區將出現最快的成長。隨著當地生產能力的提高和健康教育活動的開展，人們對酵素療法的認知也不斷提高，拉丁美洲和中東及非洲也將穩步成長。

目錄

第1章 全球消化二胺氧化酶補充劑市場執行摘要

  • 全球 DAO 補充劑市場規模和預測（2022-2032年）
  • 區域概要
  • 區隔概要
    • 依成分
    • 依最終劑型
  • 主要趨勢
  • 監管影響
  • 分析師建議與結論

第2章 全球 DAO 補充劑市場定義與研究假設

  • 研究目標
  • 市場定義
  • 研究假設
    • 包括與排除
    • 限制
    • 供給側分析
      • DAO 資源的可用性
      • 處理基礎設施
      • 監管環境
      • 競爭格局
      • 成本動態
    • 需求面分析
      • 消費者健康意識
      • 通路
      • 技術創新
      • 醫師和執業醫師的採用
  • 估算方法
  • 研究涵蓋的年份
  • 貨幣兌換率

第3章 全球 DAO 補充品市場動態

  • 市場促進因素
    • 人們對組織胺不耐受和腸道健康的認知不斷提高
    • 功能性營養和個人化營養激增
    • 酶穩定和輸送技術的進展
  • 市場挑戰
    • 新興地區消費者知識有限
    • 開採和生產成本高
    • 來自通用消化酵素混合物的競爭
  • 市場機會
    • 植物性和純素DAO替代品的開發
    • 益生菌和抗發炎活性成分的複合配方
    • 融入數位健康和遠端營養平台

第4章 全球 DAO 補充劑市場產業分析

  • 波特五力模型
    • 供應商的議價能力
    • 買家的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭對手
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 環境
    • 合法
  • 最佳投資機會
  • 最佳獲勝策略
  • 顛覆性趨勢
  • 產業專家觀點
  • 分析師建議與結論

第5章 全球 DAO 補充劑市場規模和預測：依成分，-2022-2032年

  • 細分儀表板
  • 全球 DAO 市場：成分收入趨勢分析（2022年和2032年）
    • 植物性二胺氧化酶
    • 動物源二胺氧化酶

第6章 全球 DAO 補充品市場規模與預測：依最終劑型，2022年至2032年

  • 細分儀表板
  • 全球 DAO 市場：劑型收入趨勢分析（2022年和2032年）
    • 片劑
    • 膠囊
    • 粉末
    • 其他

第7章 全球 DAO 補充劑市場規模和預測：依地區，-2022-2032年

  • 北美DAO補充劑市場
    • 美國DAO補充劑市場
    • 加拿大DAO補充劑市場
  • 歐洲DAO補充劑市場
    • 英國DAO補充劑市場
    • 德國DAO補充劑市場
    • 法國DAO補充劑市場
    • 西班牙DAO補充劑市場
    • 義大利DAO補充劑市場
    • 歐洲其他地區DAO補充劑市場
  • 亞太地區DAO補充劑市場
    • 中國DAO補充劑市場
    • 印度DAO補充劑市場
    • 日本DAO補充劑市場
    • 澳洲DAO補充劑市場
    • 韓國DAO補充劑市場
    • 亞太其他地區DAO補充品市場
  • 拉丁美洲DAO補充市場
    • 巴西DAO補充劑市場
    • 墨西哥DAO補充劑市場
    • 拉丁美洲其他地區的DAO補充市場
  • 中東和非洲 DAO 補充品市場
    • 沙烏地阿拉伯DAO補充劑市場
    • 南非DAO補充劑市場
    • 中東和非洲其他地區的DAO 補充市場

第8章 競爭情報

  • 重點公司 SWOT 分析
    • Swanson Health Products
    • NOW Foods
    • Biotech Pharmacal Inc.
  • 最佳市場策略
  • 公司簡介
    • Swanson Health Products
      • 關鍵訊息
      • 概述
      • 財務（視資料可用性而定）
      • 產品概要
      • 市場策略
    • NOW Foods
    • Biotech Pharmacal Inc.
    • Jarrow Formulas, Inc.
    • SFI Health
    • Xymogen
    • Integrative Therapeutics, LLC
    • Seeking Health
    • Pure Encapsulations, LLC
    • Nutricology Inc.
    • Kirkman Group Inc.
    • Life Extension Foundation
    • Ambe Phytoextracts Pvt. Ltd.
    • Enzymotec Ltd.
    • Natural Factors Nutritional Products Ltd.

第9章 研究過程

  • 研究過程
    • 資料探勘
    • 分析
    • 市場評估
    • 驗證
    • 出版
  • 研究屬性
簡介目錄

Global Digestive Diamine Oxidase Enzyme for Supplements Market is valued at approximately USD 23.8 billion in 2023 and is anticipated to grow with a compelling CAGR of more than 5.64% over the forecast period 2024-2032. Diamine oxidase (DAO) enzyme supplementation has emerged as a crucial dietary solution to address histamine intolerance and related digestive imbalances. As the global population becomes increasingly aware of gut health and systemic inflammation, DAO's therapeutic potential in mitigating gastrointestinal distress, migraines, and food sensitivity symptoms is driving its swift adoption in the supplements space. Market players are strategically positioning DAO within clean-label nutraceuticals, targeting health-conscious consumers actively seeking targeted enzymatic interventions for chronic digestive discomfort.

Fueling this surge is a confluence of factors: the dramatic uptick in functional food consumption, the expansion of personalized nutrition platforms, and the broader consumer shift toward holistic wellness routines. DAO's application in supplements, particularly in tablet, capsule, and powder forms, is being amplified by scientific backing and the growing visibility of histamine-related digestive disorders. Technological progress in enzyme stabilization and encapsulation is enabling higher bioavailability and shelf stability, further enhancing the commercial viability of DAO-infused formulations. Concurrently, regulatory clarity in major markets and rising inclusion of DAO in practitioner-led treatment regimens are setting the stage for broader clinical endorsement.

However, the market is not without friction points. Limited consumer awareness regarding DAO's specific role in histamine breakdown, especially in developing economies, remains a bottleneck. High production costs, along with complex extraction and purification protocols, also limit scalability. Moreover, competition from generic digestive enzyme blends and the nascent state of DAO-related research continue to pose strategic risks. Yet, these challenges are catalyzing innovation-paving the way for plant-based enzyme alternatives, vegan-compliant formulations, and co-enzymatic blends that synergize DAO with probiotics and anti-inflammatory compounds.

The integration of DAO enzymes into multi-benefit wellness supplements tailored for gut-brain axis health, skin vitality, and metabolic harmony is unlocking unprecedented commercial pathways. Influencer-led brand storytelling and direct-to-consumer distribution models are reshaping the competitive landscape, particularly in markets with digitally engaged consumers. Nutraceutical manufacturers are also collaborating with clinical researchers to design bioavailable DAO delivery mechanisms using liposomal and delayed-release technologies. This convergence of biotech and consumer trends is amplifying DAO's appeal across age groups, particularly among women and aging populations susceptible to histamine sensitivity.

Regionally, North America leads the global DAO supplements market, driven by robust dietary supplement consumption, high consumer health literacy, and strong e-commerce penetration. Europe follows closely with rising nutrigenomic applications and favorable labeling standards. Meanwhile, Asia Pacific is expected to witness the fastest growth due to increasing disposable income, greater interest in preventive healthcare, and a burgeoning wellness industry in countries such as China, Japan, and India. Latin America and the Middle East & Africa are also poised for steady growth as local production capabilities improve and health education initiatives spread awareness about enzyme-based therapies.

Major market player included in this report are:

  • Swanson Health Products
  • NOW Foods
  • Biotech Pharmacal Inc.
  • Jarrow Formulas, Inc.
  • SFI Health
  • Xymogen
  • Integrative Therapeutics, LLC
  • Seeking Health
  • Pure Encapsulations, LLC
  • Nutricology Inc.
  • Kirkman Group Inc.
  • Life Extension Foundation
  • Ambe Phytoextracts Pvt. Ltd.
  • Enzymotec Ltd.
  • Natural Factors Nutritional Products Ltd.

The detailed segments and sub-segment of the market are explained below:

By Ingredient

  • Plant-Based Diamine Oxidase
  • Animal-Based Diamine Oxidase

By Final Dosage Form

  • Tablets
  • Capsules
  • Powders
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Years considered for the study are as follows:

  • Historical year - 2022
  • Base year - 2023
  • Forecast period - 2024 to 2032

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2022 to 2032.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of geographical landscape with country-level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global Digestive Diamine Oxidase Enzyme for Supplements Market Executive Summary

  • 1.1. Global Digestive Diamine Oxidase Enzyme for Supplements Size & Forecast (2022-2032)
  • 1.2. Regional Summary
  • 1.3. Segmental Summary
    • 1.3.1. By Ingredient
    • 1.3.2. By Final Dosage Form
  • 1.4. Key Trends
  • 1.5. Regulatory Impact
  • 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Digestive Diamine Oxidase Enzyme for Supplements Definition and Research Assumptions

  • 2.1. Research Objective
  • 2.2. Market Definition
  • 2.3. Research Assumptions
    • 2.3.1. Inclusion & Exclusion
    • 2.3.2. Limitations
    • 2.3.3. Supply Side Analysis
      • 2.3.3.1. Availability of DAO Sources
      • 2.3.3.2. Processing Infrastructure
      • 2.3.3.3. Regulatory Environment
      • 2.3.3.4. Competitive Landscape
      • 2.3.3.5. Cost Dynamics
    • 2.3.4. Demand Side Analysis
      • 2.3.4.1. Consumer Health Awareness
      • 2.3.4.2. Distribution Channels
      • 2.3.4.3. Technological Innovations
      • 2.3.4.4. Physician & Practitioner Adoption
  • 2.4. Estimation Methodology
  • 2.5. Years Considered for the Study
  • 2.6. Currency Conversion Rates

Chapter 3. Global Digestive Diamine Oxidase Enzyme for Supplements Dynamics

  • 3.1. Market Drivers
    • 3.1.1. Growing Awareness of Histamine Intolerance and Gut Health
    • 3.1.2. Surge in Functional & Personalized Nutrition
    • 3.1.3. Advances in Enzyme Stabilization and Delivery Technology
  • 3.2. Market Challenges
    • 3.2.1. Limited Consumer Knowledge in Emerging Regions
    • 3.2.2. High Extraction and Production Costs
    • 3.2.3. Competition from Generic Digestive Enzyme Blends
  • 3.3. Market Opportunities
    • 3.3.1. Development of Plant Based and Vegan DAO Alternatives
    • 3.3.2. Co formulation with Probiotics and Anti inflammatory Actives
    • 3.3.3. Integration into Digital Health & Tele nutritional Platforms

Chapter 4. Global Digestive Diamine Oxidase Enzyme for Supplements Industry Analysis

  • 4.1. Porter's Five Forces Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. PESTEL Analysis
    • 4.2.1. Political
    • 4.2.2. Economic
    • 4.2.3. Social
    • 4.2.4. Technological
    • 4.2.5. Environmental
    • 4.2.6. Legal
  • 4.3. Top Investment Opportunities
  • 4.4. Top Winning Strategies
  • 4.5. Disruptive Trends
  • 4.6. Industry Expert Perspective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Digestive Diamine Oxidase Enzyme for Supplements Size & Forecast by Ingredient, 2022-2032

  • 5.1. Segment Dashboard
  • 5.2. Global DAO Market: Ingredient Revenue Trend Analysis (2022 & 2032)
    • 5.2.1. Plant Based Diamine Oxidase
    • 5.2.2. Animal Based Diamine Oxidase

Chapter 6. Global Digestive Diamine Oxidase Enzyme for Supplements Size & Forecast by Final Dosage Form, 2022-2032

  • 6.1. Segment Dashboard
  • 6.2. Global DAO Market: Dosage Form Revenue Trend Analysis (2022 & 2032)
    • 6.2.1. Tablets
    • 6.2.2. Capsules
    • 6.2.3. Powders
    • 6.2.4. Others

Chapter 7. Global Digestive Diamine Oxidase Enzyme for Supplements Size & Forecast by Region, 2022-2032

  • 7.1. North America Digestive Diamine Oxidase Enzyme for Supplements
    • 7.1.1. U.S. Digestive Diamine Oxidase Enzyme for Supplements
    • 7.1.2. Canada Digestive Diamine Oxidase Enzyme for Supplements
  • 7.2. Europe Digestive Diamine Oxidase Enzyme for Supplements
    • 7.2.1. UK Digestive Diamine Oxidase Enzyme for Supplements
    • 7.2.2. Germany Digestive Diamine Oxidase Enzyme for Supplements
    • 7.2.3. France Digestive Diamine Oxidase Enzyme for Supplements
    • 7.2.4. Spain Digestive Diamine Oxidase Enzyme for Supplements
    • 7.2.5. Italy Digestive Diamine Oxidase Enzyme for Supplements
    • 7.2.6. Rest of Europe Digestive Diamine Oxidase Enzyme for Supplements
  • 7.3. Asia Pacific Digestive Diamine Oxidase Enzyme for Supplements
    • 7.3.1. China Digestive Diamine Oxidase Enzyme for Supplements
    • 7.3.2. India Digestive Diamine Oxidase Enzyme for Supplements
    • 7.3.3. Japan Digestive Diamine Oxidase Enzyme for Supplements
    • 7.3.4. Australia Digestive Diamine Oxidase Enzyme for Supplements
    • 7.3.5. South Korea Digestive Diamine Oxidase Enzyme for Supplements
    • 7.3.6. Rest of Asia Pacific Digestive Diamine Oxidase Enzyme for Supplements
  • 7.4. Latin America Digestive Diamine Oxidase Enzyme for Supplements
    • 7.4.1. Brazil Digestive Diamine Oxidase Enzyme for Supplements
    • 7.4.2. Mexico Digestive Diamine Oxidase Enzyme for Supplements
    • 7.4.3. Rest of Latin America Digestive Diamine Oxidase Enzyme for Supplements
  • 7.5. Middle East & Africa Digestive Diamine Oxidase Enzyme for Supplements
    • 7.5.1. Saudi Arabia Digestive Diamine Oxidase Enzyme for Supplements
    • 7.5.2. South Africa Digestive Diamine Oxidase Enzyme for Supplements
    • 7.5.3. Rest of Middle East & Africa Digestive Diamine Oxidase Enzyme for Supplements

Chapter 8. Competitive Intelligence

  • 8.1. Key Company SWOT Analysis
    • 8.1.1. Swanson Health Products
    • 8.1.2. NOW Foods
    • 8.1.3. Biotech Pharmacal Inc.
  • 8.2. Top Market Strategies
  • 8.3. Company Profiles
    • 8.3.1. Swanson Health Products
      • 8.3.1.1. Key Information
      • 8.3.1.2. Overview
      • 8.3.1.3. Financial (Subject to Data Availability)
      • 8.3.1.4. Product Summary
      • 8.3.1.5. Market Strategies
    • 8.3.2. NOW Foods
    • 8.3.3. Biotech Pharmacal Inc.
    • 8.3.4. Jarrow Formulas, Inc.
    • 8.3.5. SFI Health
    • 8.3.6. Xymogen
    • 8.3.7. Integrative Therapeutics, LLC
    • 8.3.8. Seeking Health
    • 8.3.9. Pure Encapsulations, LLC
    • 8.3.10. Nutricology Inc.
    • 8.3.11. Kirkman Group Inc.
    • 8.3.12. Life Extension Foundation
    • 8.3.13. Ambe Phytoextracts Pvt. Ltd.
    • 8.3.14. Enzymotec Ltd.
    • 8.3.15. Natural Factors Nutritional Products Ltd.

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes